Pharma Execs Boost Prices to Boost Pay

The House Oversight Committee released two major reports Wednesday that expose the internal strategies used by drug makers Celgene and Teva to repeatedly jack up the price of their blockbuster drugs revlimid and copaxone. The reports, which are the culmination of an 18-month investigation based on internal company documents, outline in vivid detail how both…